
differentiate between the symptoms related to recovery
from the original procedure and residual symptoms from
remaining venous insufÔ¨Åciency. We recommend followup for a minimum of 3 months to determine whether
the procedure has both resolved the symptoms and
eliminated visible tributary veins. Longer follow-up is
recommended for patients with recurrent symptoms
and those participating in clinical trials. In patients with
residual symptoms, DU should be performed to assess
the treated veins for closure and